Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New powder dressing aims to ease burn pain

NCT ID NCT05424354

Symptom relief Sponsor: ULURU Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new powder dressing called Altrazeal to standard burn dressings in adults with partial thickness burns. The goal is to see if the new dressing reduces pain during changes and helps wounds heal faster. Sixty hospitalized patients will be randomly assigned to one of the two treatments and followed for up to 28 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Altrazeal Transforming Powder Dressing (a device)
What this could lead to
If it works, this could offer a less painful dressing option for burn patients and potentially speed up healing.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The new dressing might not be better than current standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2022

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hospitalized patients who are receiving burn care; patients may be discharged when clinically stable and continue with outpatient treatment. * Men and women (women cannot be pregnant or breast feeding) ages 18-65 years old * Wounds must be partial thickness, involving up to 20% of the total body surface area. * Burn injury should be less than 72 hours old * Willing and able to comply with protocol mandated scheduled study visits/clinical evaluations. * Willing and able to provide written informed consent. Exclusion Criteria: * Known allergy to TPD or its components * Women who are pregnant, breast feeding, or plan to get pregnant during the study period. * Infected wounds * Presence of any full thickness (third degree) burns * Electrical burns * Heavily draining burns due to underlying chronic lymphedema or other conditions * Concurrent clinical condition within the judgement of the clinician, pose a health risk to the patient, delay wound healing, or otherwise influence the outcome of the study. * History of poor wound healing and/or skin/immune system condition * Deemed by clinician not to be suitable * Unwilling or not able to provide consent or comply with protocol or required visits * Developmental disability/significant psychological disorder which can impair the subjects ability to provide informed consent, or participate in the study protocol * Active alcohol or substance abuse

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Wounds and injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

burn injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Wounds and injuries

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Jackson Memorial Hospital UM/JMH Burn Center

    RECRUITING

    Miami, Florida, 33136, United States

  • MedStar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • University of California-Irvine

    RECRUITING

    Orange, California, 92868, United States

  • University of Louisville Health

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • University of Texas SW (Parkland)

    RECRUITING

    Dallas, Texas, 75235, United States

  • Westchester Medical Center

    RECRUITING

    Valhalla, New York, 10595, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.